Close Menu

NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Tuesday that its fourth quarter revenues rose 7 percent year over year, in line with preliminary Q4 revenues reported in January.

For the three months ended Dec. 31, the company reported revenues of $16.0 million, up from $14.9 million in Q4 2016, and beating the analysts' consensus estimate of $15.6 million for the quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.